Data-driven nanomedicine

To form a world-class research group; to transition to a new paradigm in the creation of nanostructured drugs and biomaterials – a paradigm based on big data and predictive machine and deep learning algorithms. At the core of the new paradigm will be the application of high-performance data generation methods, algorithms for automated data collection and prediction of nanoformulation properties, as well as express screening platforms for preclinical validation of promising treatments